The New Jersey Supreme Court Has Adopted the Expert Admissibility FACTORS AND Gatekeeping Function of the Trial Court's Enunciat
Facing thousands of Accutane claims, Roche wins appeal of $18M jury verdict | Fierce Pharma
Untitled
SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-4760-14T1 A-0164-15T1 IN RE: ACCUTANE LITIGATION
New Jersey Expert Admissibility Standard: “Reconciled” with Daubert
2020 Thomson Reuters. No claim to original U.S. Government Works. 1 235 N.J. 229 Supreme Court of New Jersey. IN RE: ACCUTANE
NJ Justices Say Garden State Law Topples Accutane Cases
Untitled
ORDER TO DELETE submitted by Case Management Staff October 30, 2017 | Trellis
Accutane Lawsuit Status – Injuries & Jury Verdicts
A-25-17 In re: Accutane Litigation (079958)
In re Accutane Litigation, 234 N.J. 340 (N.J. 2018)
New Jersey Appellate Panel Reverses Trial Court's Detailed Exclusion of Unreliable Expert Testimony - Life Science Matters
Another Expert Exclusion Order Secured by Colleen Hennessey and Team in New Jersey Accutane-IBD Litigation is Affirmed by the New Jersey Appellate Division – Peabody & Arnold
Supreme Court of New Jersey Archives - Government & Law Blog
Order Admitting To Practice Pro Hac Vice - Marie Woodbury
Order Granting Summary Judgment on Lack of Proximate Cause Schedule A and Schedule B
$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations - Litigation Blog - Litigation - LexisNexis® Legal Newsroom
NJ Court's Exclusion of Experts in Accutane Litigation
Roche faces more than 2K Accutane liability cases as appeals panels reverse rulings | Fierce Pharma
New Jersey Supreme Court Sets Higher Standards For Expert Opinions | Respond Law
Everything You Need to Know About Microdosing Accutane for Acne
Untitled
